Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

Name: Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
SKU: 22778
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 49 No. 1 Articles 2019 Tags: autonomic symptoms, Camilla Callegari, Celeste Isella, cognitive-impairment, Fabiana Pettenon, Giulia Lucca, Ivano Caselli, Marcello Diurni, Marta Ielmini, Nicola Poloni, paroxetine, post-menopausal depression, vortioxetine

Description

Description

Evidence-Based Medicine

Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

By Camilla Callegari, Marta Ielmini, Ivano Caselli, Giulia Lucca, Celeste Isella, Marcello Diurni, Fabiana Pettenon, Nicola Poloni

28-43_PB-49-1-2019-Callegari

Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

Description

Evidence-Based Medicine

Clinical Management of Perinatal Depression: Focus on Paroxetine

Treatment of Panic Disorder: Focus on Paroxetine

Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine

Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

Description

Evidence-Based Medicine

Related products

Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents

Clinical Management of Perinatal Depression: Focus on Paroxetine

Treatment of Panic Disorder: Focus on Paroxetine

Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine